Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Fluoxetine

Fluoxetine
In stock
10mg · 20mg · 60mg
from A$62.14
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$74.57A$62.14
A$2.07 per capsule

In brief

  • You can obtain fluoxetine from pharmacies; in the markets cited it is officially prescription-only (Rx/POM), though availability varies and some pharmacies or online vendors may supply it without a prescription—check local laws and pharmacy policies.
  • Fluoxetine is an SSRI antidepressant used to treat major depressive disorder, obsessive–compulsive disorder, bulimia nervosa, panic disorder and premenstrual dysphoric disorder; it works by selectively inhibiting serotonin reuptake, increasing serotonin levels in the brain.
  • Typical starting dose is 20 mg once daily for adults; doses may be adjusted (commonly 20–60 mg/day) depending on indication and response, with higher doses used in some conditions; maximum usual doses may reach 80 mg in specialist care.
  • Fluoxetine is taken orally — available as capsules, tablets (including orodispersible tablets), and oral solution.
  • Some people notice initial improvement within 1–2 weeks, but clinically meaningful antidepressant effects usually take 4–6 weeks to develop.
  • Fluoxetine has a long duration of action: the parent drug has a long half-life (several days) and its active metabolite norfluoxetine persists for about 1–2 weeks, so effects can last days to weeks after stopping.
  • Avoid or limit alcohol while taking fluoxetine, as alcohol can worsen mood symptoms and increase side effects such as drowsiness or impaired coordination.
  • The most common side effects include nausea (often transient); other frequent effects are headache, insomnia or sleep changes, and sexual dysfunction.
  • Would you like to try fluoxetine without a prescription?

Safety, Warnings And Patient Protection (Australia)

Basic Fluoxetine Information

  • INN (International Nonproprietary Name): Fluoxetine
  • Brand Names Available In Australia: Not specified
  • ATC Code: N06AB03
  • Forms & Dosages: Hard capsules 10 mg, 20 mg, 30 mg, 40 mg, 60 mg; oral solution 20 mg/5 mL; orodispersible tablets 20 mg
  • Manufacturers In Australia: Not specified
  • Registration Status In Australia: Not specified
  • OTC / Rx Classification: Prescription only

High‑Risk Groups

Who Is More Vulnerable When Starting Fluoxetine?

Prioritise safety: fluoxetine can cause serious adverse effects in particular groups.

Older adults taking many medicines (polypharmacy) are at higher risk of drug interactions and falls.

Pregnant people and those who are breastfeeding need individual risk–benefit discussion before starting fluoxetine.

Adolescents and young adults under 25 have an increased risk of suicidal ideation when starting antidepressants and must be monitored closely.

People with known bipolar disorder may switch into mania if an antidepressant is started without a mood stabiliser; screen for past hypomania or mania.

Uncontrolled epilepsy or recent seizures increase seizure risk; review seizure history and coordinate with neurology.

Severe cardiac disease requires assessment of QT risk and baseline cardiac history before initiation.

Baseline Checks To Do Before Dispensing

  • Ask about past bipolar symptoms and perform a bipolar screen where appropriate.
  • Check seizure history and current antiepileptic medicines.
  • Confirm pregnancy test status if pregnancy is possible and discuss contraception as relevant.
  • Review all current medicines including over‑the‑counter products and herbal supplements such as St John’s wort.
  • Document informed consent and shared decision making in the patient record.
  • Refer to a psychiatrist or specialist when risk is elevated or diagnosis is uncertain.

Interaction With Activities (Driving, Workplace Safety)

Does Fluoxetine Affect Driving And Other Safety‑Critical Tasks?

Fluoxetine may cause drowsiness, dizziness or slowed reaction time, especially during the first weeks or after dose increases.

Under Australian workplace safety laws, including guidance from Safe Work Australia, workers in safety‑critical roles must be counselled about potential impairment.

If a patient performs driving, operates heavy machinery or works in aviation, advise them not to undertake those tasks until they know how fluoxetine affects them.

Advise patients to follow employer reporting duties if they work in safety‑critical positions and to check workplace policies on fitness for duty.

Q&A — Can I Drive After Taking It In Australia?

Q: Can I drive after taking it in Australia?

A: Most people can drive once they know how fluoxetine affects them; avoid driving if you feel drowsy, dizzy or impaired.

Disclose impairment if in safety‑critical roles and follow employer guidance.

  • Urgent Red‑Flag Symptoms: New or worsening suicidal thoughts, sudden severe agitation, severe insomnia, sudden chest pain, severe allergic reaction (rash, swelling, breathing difficulty), signs of serotonin syndrome (high temperature, rapid heartbeat, muscle stiffness, confusion).
  • Checklist For Screening High‑Risk Groups: Age under 25; pregnancy/breastfeeding status; history of bipolar disorder; seizure history; significant cardiac disease; current medicines including OTC and herbal products; signs of polypharmacy.

Usage Basics (Identity, Legal Status, Formulations)

Core Identity And Legal Classification

What Is Fluoxetine And How Is It Classified?

Fluoxetine is an SSRI antidepressant whose INN is fluoxetine.

The active substance is commonly listed as fluoxetine hydrochloride in product information.

The ATC code for fluoxetine is N06AB03, classifying it within antidepressants as an SSRI.

Fluoxetine is prescription‑only in the compiled product data and should be supplied on a valid prescription in Australia.

Always check the TGA ARTG entry and the sponsor‑specific Product Information (PI) or SmPC for details that may affect prescribing.

Brand Names And Formulations

What Forms Does Fluoxetine Come In?

Product Form Strengths Examples
Hard Capsules 10 mg, 20 mg, 30 mg, 40 mg, 60 mg Generic fluoxetine capsules (various sponsors)
Oral Solution 20 mg/5 mL Clear peppermint‑odour solution (contains sucrose)
Orodispersible Tablets 20 mg Prozac 20 mg orodispersible (reported internationally)
  • Quick Checks Before Prescribing: Confirm formulation availability locally; check patient preference for capsules vs oral solution or orodispersible tablets; verify sponsor PI for formulation‑specific excipients (e.g. sucrose in oral solution).
  • Use fluoxetine 20mg as a common reference dose for initiation in many adult regimens, adjusting for clinical circumstances.

Dosing Guide And Adjustments

Standard Regimens

How Is Fluoxetine Usually Dosed?

Typical adult starting doses are conservative — commonly 10–20 mg once daily, titrating to effect over weeks.

Maintenance doses often range 20–40 mg daily, with some patients on higher doses such as 60 mg under specialist supervision.

Elderly patients, people with hepatic impairment or significant comorbidity usually start on a lower dose and require closer monitoring for side‑effects.

Paediatric and adolescent dosing differs and should follow paediatric psychiatry guidance and the TGA SmPC for age‑related approvals and safety information.

Adjustments For Comorbidities

How Should Dosing Be Altered For Other Health Conditions?

Reduce starting dose in hepatic impairment and monitor plasma effects if the patient is frail or has significant comorbidity.

Review QT prolongation risk in people with cardiac disease and avoid combining multiple QT‑prolonging medicines where possible.

Do not abruptly start or stop antidepressants in patients with bipolar disorder without mood‑stabiliser cover; consult psychiatry as needed.

Assess seizure threshold where epilepsy is present and coordinate dosing with neurology or the treating clinician.

Coordinate closely with specialists when polypharmacy or complex medical histories are present to avoid interactions and adverse outcomes.

Q&A — What If I Miss A Dose?

If you miss a single dose take it when you remember unless it is nearly time for the next dose.

Do not double up to make up for a missed dose.

For repeated missed doses, ongoing confusion about dosing, or signs of withdrawal or worsening mood contact your GP or pharmacist for advice.

  • Starting Dose Checks: Confirm indication, current medicines, pregnancy risk and age before first supply.
  • Monitoring Schedule: Follow up within 1–2 weeks after initiation, then regularly for 6–12 weeks to assess response and side‑effects.
  • Blood Tests Where Relevant: Routine blood tests are not required for most patients, but monitor INR if on warfarin and check clinical parameters if on interacting drugs.

Interaction Chart (Drugs, Foods, Supplements)

Food, Drink And Supplements

Which Everyday Substances Interact With Fluoxetine?

Alcohol can worsen depression and increase sedation, so advise avoiding heavy drinking while starting or while the dose is changing.

Caffeine may heighten anxiety or worsen insomnia but has no prominent CYP interaction with fluoxetine.

Avoid St John’s wort because combining it with fluoxetine raises the risk of serotonin syndrome.

Grapefruit interactions are not prominent with fluoxetine; still, check sponsor product information for formulation‑specific advice.

Common Drug Conflicts

Key Drug Classes To Watch When Fluoxetine Is Prescribed

Avoid co‑prescription with MAOIs because of the risk of serotonin syndrome; allow appropriate washout periods when switching classes.

Be cautious combining fluoxetine with other serotonergic drugs such as triptans, tramadol or other SSRIs/SNRIs because of additive serotonin risk.

Monitor for QT prolongation when fluoxetine is used with antipsychotics or other QT‑prolonging medicines.

Fluoxetine is a moderate inhibitor of CYP2D6 and can increase exposure to drugs metabolised by CYP2D6 such as some antipsychotics, beta‑blockers and codeine (reducing codeine activation).

Patients on warfarin should have INR monitored after starting or stopping fluoxetine due to possible effects on anticoagulant response.

Drug Class Interaction Concern Recommended Clinical Action
MAO Inhibitors Risk of serotonin syndrome Do not combine; observe washout periods per SmPC
Other Serotonergic Agents (triptans, tramadol, SNRIs) Increased serotonin syndrome risk Use caution; monitor closely and counsel patient on symptoms
QT‑Prolonging Drugs (certain antipsychotics, macrolides) Potential additive QT prolongation Assess QT risk, ECG if indicated, avoid combinations when possible
CYP2D6 Substrates (codeine, some antipsychotics, beta‑blockers) Increased plasma levels of substrate; reduced codeine activation Adjust dose if needed, monitor effects, avoid codeine for analgesia where possible
Warfarin Altered anticoagulant effect Monitor INR after starting or stopping fluoxetine
  • Immediate Actions For Suspected Serotonin Syndrome: Stop all serotonergic medicines, call emergency services if severe, seek urgent medical review, manage hyperthermia, seizures and autonomic instability in hospital.

User Reports & Trends (Australia)

What Do Australian Patients Say About Fluoxetine?

On forums and review sites patients commonly report a variable onset of action.

Many describe some mood improvement after 2–4 weeks and a more complete benefit by 6–8 weeks.

Frequently reported side‑effects include nausea, reduced libido, insomnia or vivid dreams, and transient anxiety during initiation.

Long‑term anecdotal reports are mixed: some patients report sustained benefit, while others report persistent sexual dysfunction or a sense of emotional blunting.

Limitations And Regional Considerations

Online reviews are anecdotal and influenced by selection bias and individual expectations.

Interpret user reports alongside clinical evidence rather than using them as sole guidance for treatment decisions.

Rural patients may report longer waits for specialist review and rely more on pharmacists, telehealth and community mental health services for support.

  • Common Patient‑Reported Benefits: Improved mood, reduced anxiety, better sleep after adjustment, relief from binge‑purge behaviour in bulimia (reported anecdotally).
  • Common Patient‑Reported Harms: Nausea, sexual side‑effects, initial increased anxiety, vivid dreams, emotional flattening.

Sources For Reviews

Patient review sites such as ProductReview and mental health forums reflect consumer trends but should be cited with caution and supplemented by clinical guidance.

Access & Purchase Options (How Australians Obtain Fluoxetine)

Prescribing And Dispensing Pathways

How Do Patients Get Fluoxetine In Australia?

Fluoxetine is obtained via a prescription from a GP, psychiatrist or nurse practitioner.

Telehealth consultations and e‑prescriptions are widely used across Australia and are commonly accepted by community pharmacies.

Pharmacies dispense on presentation of a valid prescription and provide mandatory counselling at supply.

Retail And Online Supply

Where Can Fluoxetine Be Supplied?

Major pharmacy chains that commonly stock fluoxetine include Chemist Warehouse, Priceline and TerryWhite Chemmart, alongside independent community and hospital pharmacies.

Use only TGA‑registered online pharmacies that require a valid prescription to ensure legal and safe supply.

In our online pharmacy, fluoxetine is available without a prescription, with discreet delivery to Australia in 9-21 days.

Rural Vs Urban Considerations

What Differs For Rural Patients?

Rural patients may need locum prescriber services and telepsychiatry to obtain specialist input in a timely way.

Dispensing intervals may be longer and pharmacies should rotate stock and maintain buffers to reduce supply gaps.

Pharmacy Type Service Typical Turnaround PBS Status
Major Chain (in‑store) In‑store dispensing, counselling Same day to 1–2 days May be PBS listed depending on indication and authority
Major Chain (online) Online ordering, prescription upload 2–7 days plus delivery Requires prescription; PBS processes apply
Independent Pharmacy In‑store dispensing, personalised counselling Same day to 1–3 days PBS applies where relevant
Hospital Pharmacy Dispensing for inpatients/outpatients Same day (inpatient) to a few days (outpatient) May dispense under hospital policies; PBS involvement varies
  • What To Bring To The Pharmacy: Valid prescription, photo ID if requested, full medicines list including OTC and herbal products, and a summary of medical history for the pharmacist.
  • Note: Call ahead to confirm stock and PBS concession eligibility to avoid travel or delays.

Mechanism & Pharmacology (Simple + Clinical Meaning)

How Does Fluoxetine Work?

Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin availability at synapses by blocking the serotonin transporter.

This change in serotonin signalling can improve mood, reduce anxiety and treat some obsessive‑compulsive symptoms over several weeks.

Fluoxetine is lipophilic and has a relatively long half‑life compared with many other SSRIs.

The active metabolite norfluoxetine contributes to prolonged effects and influences dosing intervals and switching strategies between antidepressants.

Clinical Implications

The long half‑life means missed‑dose guidance and tapering strategies differ from short‑acting SSRIs and can reduce the risk of discontinuation symptoms when stopping fluoxetine.

Fluoxetine’s moderate CYP2D6 inhibition explains several clinically relevant drug interactions and necessitates review of CYP2D6 substrates.

Pharmacokinetic differences should guide washout periods and cross‑tapering; consult specialist guidance for complex switches.

SSRI
Selective Serotonin Reuptake Inhibitor — increases serotonergic neurotransmission by blocking the serotonin transporter.
INN
Fluoxetine — the internationally recognised nonproprietary name.
ATC
N06AB03 — category for SSRIs in the Anatomical Therapeutic Chemical classification.
Half‑Life
Relatively long; active metabolite norfluoxetine extends duration of effect and affects switching strategies.
Active Metabolite
Norfluoxetine — contributes to prolonged pharmacological activity.

Indications & Off‑Label Uses

Registered Indications

What Is Fluoxetine Approved For?

Check the current TGA Product Information for registered indications in Australia for sponsor‑specific approvals.

Internationally fluoxetine is commonly approved for major depressive disorder, obsessive‑compulsive disorder, bulimia nervosa and panic disorder, though age and formulation approvals differ by sponsor.

Off‑Label Prescribing

When Might Fluoxetine Be Used Off‑Label?

Clinicians sometimes prescribe fluoxetine off‑label for other anxiety disorders, premenstrual dysphoric disorder or treatment‑resistant presentations where evidence supports benefit.

Off‑label prescribing requires documented informed consent and a clear clinical rationale recorded in the medical record.

  • Approved Indications: Major depressive disorder; obsessive‑compulsive disorder; bulimia nervosa (internationally recognised depending on sponsor).
  • Common Off‑Label Uses: Certain anxiety disorders, premenstrual dysphoric disorder, and some cases of treatment resistance with psychiatric oversight.
Indication Evidence Level PBS Funding Status
Major Depressive Disorder High (SSRI class evidence) Variable — check PBS Schedule and authority rules
Obsessive‑Compulsive Disorder Moderate to High Variable — check PBS
Bulimia Nervosa Moderate Variable

Always document discussions and provide written patient information about the intended use and expected outcomes.

Key Clinical Findings & Guideline Alignment

What Does The Evidence Say?

Systematic reviews and clinical guidelines support the use of SSRIs, including fluoxetine, for moderate‑to‑severe major depressive disorder and for certain anxiety and OCD presentations.

Response to treatment varies between individuals and a full therapeutic effect commonly takes several weeks to appear.

Long‑term benefit and side‑effects should be reviewed regularly and treatment personalised by comorbidity, tolerability and patient preference.

Australian bodies such as the Royal Australian College of General Practitioners and NHMRC‑aligned guidance mirror international recommendations to individualise antidepressant selection.

  • Top Trials/Meta‑Analyses: Meta‑analyses generally show SSRIs are effective over placebo for moderate‑to‑severe depression, with small differences between agents; tolerability and prior response guide drug choice.
  • Key Takeaway: Use patient history and side‑effect profiles to choose an antidepressant; monitor closely for early adverse events in younger patients.
  • Adverse Event Reporting: Report suspected adverse events to the TGA to support post‑market safety monitoring and escalate to hospital where reactions are severe.

Alternatives Matrix (Comparison And Checklist)

How Does Fluoxetine Compare With Other Antidepressants?

Choice of antidepressant depends on symptom profile, prior response, side‑effect tolerability and comorbid conditions.

Drug Typical Starting Dose Common Side‑Effects PBS Status Notes On Sexual Dysfunction & Weight
Fluoxetine 10–20 mg daily Nausea, insomnia, sexual dysfunction Variable — check PBS Can cause sexual side‑effects; weight effects variable
Sertraline 50 mg daily Nausea, diarrhoea, sexual dysfunction Listed on PBS for various indications Similar sexual side‑effect profile
Escitalopram 10 mg daily Headache, nausea, sexual dysfunction Listed on PBS in some cases Often well tolerated
Venlafaxine 75 mg daily Increased BP, nausea, sexual dysfunction Listed on PBS for certain indications Monitor BP
Mirtazapine 15 mg nocte Sedation, increased appetite, weight gain PBS listed variably Lower sexual side‑effect burden; weight gain common
  • Pros And Cons Checklist By Class: SSRIs — generally well tolerated and first‑line; SNRIs — useful for neuropathic pain but watch BP; mirtazapine — useful for insomnia and weight loss but causes weight gain; TCAs — effective but less well tolerated and higher overdose risk.
  • Switching Notes: Allow appropriate washout when changing to or from MAOIs and consult specialist pharmacology guidance for complex switches.
  • Monitoring Checklist: Baseline weight, sexual function screening, blood pressure where relevant, and suicide risk review especially in younger people.

Common Questions From Pharmacy Consultations

What Should Patients Expect In The First Weeks?

Early effects can include nausea, headache, sleep changes and a transient increase in anxiety; these often settle with time.

Sexual side‑effects may appear after several weeks and can persist in some patients.

Pregnancy And Breastfeeding: Discuss risks and benefits with the prescriber and consider obstetric psychiatry input rather than stopping suddenly.

Storage And Disposal: Keep medicines out of reach of children and return unwanted or expired medicines to a pharmacy for safe disposal.

  • Top 10 Pharmacy FAQs With Succinct Answers:
    1. How long until it works? — Some improvement in 2–4 weeks; fuller benefit by 6–8 weeks.
    2. Can I drink alcohol? — Avoid heavy drinking while starting or changing dose.
    3. What about sexual side‑effects? — They can occur; discuss alternatives if troublesome.
    4. Can I stop suddenly? — Do not stop abruptly without medical advice.
    5. Is it safe in pregnancy? — Discuss with your prescriber and maternity team.
    6. Can children take it? — Paediatric dosing differs; follow specialist guidance.
    7. What if I feel worse? — Seek urgent help for worsening mood or suicidal thoughts.
    8. How to store it? — In the original container, away from heat and moisture.
    9. Can I get it online? — Use only TGA‑registered online pharmacies that require a prescription.
    10. Do I need blood tests? — Not routinely, but monitor INR with warfarin and drug‑specific checks as directed.

If mood worsens or suicidal thoughts emerge seek immediate help — call 000 in emergencies or Lifeline on 13 11 14 for crisis support.

Pharmacists should escalate concerns to the prescriber when safety issues arise.

Price & Access Comparison (Practical Table)

Cost And Subsidy Overview

Retail prices for brand and generic fluoxetine vary by supplier and pack size.

PBS listings can reduce patient cost for eligible concession and general patients; check the PBS Schedule and pharmacy pricing tools for current figures.

Pharmacy / Source Typical Price Range (Unsubsidised) PBS Subsidy Status Prescription Required Online Purchase Allowed
Chemist Warehouse Varies by pack size Variable — check PBS and authority Yes Yes (with prescription)
Priceline Varies by pack size Variable Yes Yes (with prescription)
TerryWhite Chemmart Varies by pack size Variable Yes Yes (with prescription)
Independent Pharmacy Varies Variable Yes Often (with prescription)
Hospital Pharmacy Depends on hospital policy May differ Yes Usually no
  • Access Checklist: Confirm prescription validity, bring PBS card if eligible, check pharmacist counselling availability, ask about delivery and stock, and compare total cost including dispensing fees.
  • Pharmacies sometimes offer discount programs; compare final price rather than headline cost when choosing where to fill a prescription.

Registration & Regulation (TGA, PBS, Safety Reporting)

Who Regulates Fluoxetine In Australia?

Check the Therapeutic Goods Administration (TGA) Australian Register of Therapeutic Goods (ARTG) for product entries, sponsor details and formulation specifics.

Prescription‑only status in the assembled product data aligns with TGA scheduling and legal supply requirements.

PBS listings, authority requirements and indication criteria can change; consult the PBS Schedule and prescribers for current entitlement and authority processes.

Generic interchange and brand substitution policies are governed by TGA and pharmacy practice, and pharmacists must follow state regulations.

Report suspected adverse reactions via the TGA Adverse Event Management System to support post‑market safety monitoring.

TGA
Therapeutic Goods Administration — regulator for therapeutic goods in Australia.
ARTG
Australian Register of Therapeutic Goods — list of registered products and sponsors.
PBS
Pharmaceutical Benefits Scheme — subsidy system for eligible medicines.
SmPC / PI
Summary of Product Characteristics / Product Information — sponsor‑specific clinical details and prescribing information.

Storage & Handling (Household & Pharmacy)

How Should Fluoxetine Be Stored?

Household Storage: Keep fluoxetine in the original container, tightly closed and out of reach of children and pets.

Protect from excessive heat and moisture which can be common in some Australian climates; avoid storing medicines in bathrooms.

Check expiry dates and return expired or unwanted medicines to a pharmacy for safe disposal.

Pharmacy Storage

Fluoxetine is an oral medicine that does not require a cold chain and should be stored per sponsor SmPC temperature guidance.

Pharmacies should monitor expiry dates and rotate stock, with rural services maintaining buffers to avoid shortages.

  • Household Storage Checklist: Original container, cool dry place, out of reach of children, check expiry dates, keep a medicines list accessible.
  • Travel Tips: Carry medicines in original packaging with prescription or pharmacist note, include generic name fluoxetine to avoid confusion with overseas brands.
  • Emergency Ingestion Steps: For suspected overdose in a child or adult call 000 immediately and take the medicine container to hospital or call Poisons Information Centre on 13 11 26 for advice.

Guidelines For Proper Use (Pharmacist & Prescriber Counselling)

How Should Pharmacists Counsel Patients Starting Fluoxetine?

Begin counselling with a safety screen — confirm pregnancy risk, age under 25, current medicines and any suicidal ideation.

Provide plain‑language information on expected timeline to benefit, common side‑effects and key interactions such as MAOIs and St John’s wort.

Offer written action plans and recommend follow‑up contact within 1–2 weeks after initiation.

Tapering And Discontinuation

Because fluoxetine has a long half‑life, gradual dose reduction is often smoother than with short‑acting SSRIs, though specialist input is recommended for complex cases.

Warn patients about possible discontinuation symptoms if other short‑acting antidepressants are stopped abruptly during switching.

  • Counselling Checklist: Indication and expected timeline; how to take the medicine; common and serious side‑effects; interactions; when to seek urgent care; storage and follow‑up plan.
  • Monitoring Timeline: Phone or in‑person check at 1–2 weeks, clinical review at 4–6 weeks, ongoing reviews thereafter to assess response and tolerability.
  • Escalation Pathway: Worsening mood or suicidal thoughts — immediate medical review or emergency services; severe allergic reaction or serotonin syndrome — emergency department.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Geelong Victoria 9-14 days
Cairns Queensland 14-21 days
Sunshine Coast Queensland 14-21 days

Related products